HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

House Bill Seeks Asbestos Warnings On Unverified Kids' Cosmetics With Talc

This article was originally published in The Rose Sheet

Executive Summary

You may also be interested in...



FDA Shopping For 3D Tissue Bioprinter, Cosmetic Contamination Testing Services

Recent procurement activities show an agency increasingly focused on cosmetics’ safety vis-a-vis microbial threats and, in the case of talc-containing products, asbestos. Meanwhile, FDA seeks a 3D bioprinter to use in organ toxicity studies as an alternative to traditional animal models.

Cosmetic Talc Under Scrutiny As Liability Buzzards Circle

Plaintiff’s attorneys are tracking reports of asbestos-contaminated cosmetics at specialty retail stores, signaling a possible new wave of talc-related litigation to come. The issue also has the attention of NGOs, legislators and FDA.

‘Asbestos-Free’ A Relative Term? SAI Testing Expert On Cosmetic Talc Challenges

Transmission electron microscopy is likely the safest bet, among other imaging technologies, for companies looking to verify their cosmetic talc as asbestos-free. However, there’s no regulatory-mandated method for cosmetics purposes, which may explain conflicting results being reported by different labs.  

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121472

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel